AAD: Adult Acne Clinic Visits Increase With Exposure to Wildfire-Related Air Pollution
By Tina Brown HealthDay Reporter
FRIDAY, March 15, 2024 -- Short-term exposure to wildfire-related air pollution is associated with an increase in clinic visits for acne vulgaris among adults, according to a study presented at the annual meeting of the American Academy of Dermatology, held from March 8 to 10 in San Diego.
Alex Ha, from the University of California, San Francisco, and colleagues conducted a retrospective cohort study to determine environmental triggers and factors for acne vulgaris. Dermatology clinic visits for acne vulgaris at an academic tertiary care center in San Francisco before, during, and after the 2018 California Camp Fire were compared to patient visits during the same period in 2015 and 2016 when there were no wildfires. A total of 2,054 visits for 1,549 patients were analyzed. Three metrics of wildfire-associated air pollution were assessed: PM2.5 concentration, fire status, and satellite-based smoke plume density scores.
The researchers found that an increase in weekly PM2.5 concentration of 10 µg/m3 was associated with a 2.3 percent increase in adult acne clinic visits at lag week 0 (95 percent confidence interval, 0.17 to 4.6 percent). When adjusting for temperature, humidity, age, and clinic volume, the rate of adult acne clinic visits during the California Camp Fire was 1.2-fold higher (95 percent confidence interval, 1.02 to 1.42) than the rate of visits during nonfire weeks at lag 0. For smoke plume density, the adjusted rate ratio was 1.14 (95 percent confidence interval, 1.01 to 1.28) at lag 0. No significant associations were observed for pediatric patients across the exposure metrics.
"With the worldwide increasing frequency and intensity of wildfires, these findings can inform patient counseling and management," the authors write.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted March 2024
Read this next
Bimekizumab Yields Meaningful Response in Hidradenitis Suppurativa
THURSDAY, May 30, 2024 -- Bimekizumab is well tolerated and produces clinically meaningful responses in patients with hidradenitis suppurativa, according to a study published...
Tattoos May Increase Risk of Malignant Lymphoma
WEDNESDAY, May 29, 2024 -- Tattoo exposure is associated with an increased risk of several malignant lymphoma subtypes, according to a study published online in the June issue...
Acrochordons May Be Marker for Metabolic Disease in Children
TUESDAY, May 21, 2024 -- In pediatric patients, acrochordons may be a marker for metabolic disease, according to a study published online April 29 in Pediatric...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.